Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

[Advantages and drawbacks of current pharmacological treatments for smoking cessation].

García-Galbis Marín J, Leal Hernández M, Hernández Menarguez F, Abellán Alemán J.

Semergen. 2012 Nov-Dec;38(8):505-10. doi: 10.1016/j.semerg.2012.04.018. Epub 2012 Aug 28. Spanish.

PMID:
23146703
[PubMed - in process]
2.

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Cahill K, Stevens S, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 May 31;5:CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.

PMID:
23728690
[PubMed - indexed for MEDLINE]
3.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103. doi: 10.1002/14651858.CD006103.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD006103.

PMID:
18646137
[PubMed - indexed for MEDLINE]
4.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
[PubMed - indexed for MEDLINE]
5.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
[PubMed - indexed for MEDLINE]
6.

Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.

Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.

PMID:
19715382
[PubMed - indexed for MEDLINE]
7.

Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.

Jiménez-Ruiz CA, Fagerström KO.

Monaldi Arch Chest Dis. 2013 Mar;79(1):27-32. Review.

PMID:
23741943
[PubMed - indexed for MEDLINE]
8.

[Drugs used to treat nicotine addiction].

Zieleń I, Sliwińska-Mossoń M, Milnerowicz H.

Przegl Lek. 2012;69(10):1098-102. Review. Polish.

PMID:
23421099
[PubMed - indexed for MEDLINE]
9.

Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.

Aubin HJ, Luquiens A, Berlin I.

Br J Clin Pharmacol. 2014 Feb;77(2):324-36. doi: 10.1111/bcp.12116.

PMID:
23488726
[PubMed - in process]
10.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006103. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD006103.

PMID:
17253581
[PubMed - indexed for MEDLINE]
11.

Prescribing of smoking cessation medication in England since the introduction of varenicline.

Langley TE, Huang Y, McNeill A, Coleman T, Szatkowski L, Lewis S.

Addiction. 2011 Jul;106(7):1319-24. doi: 10.1111/j.1360-0443.2011.03426.x. Epub 2011 May 3.

PMID:
21395894
[PubMed - indexed for MEDLINE]
12.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD006103. doi: 10.1002/14651858.CD006103.pub6. Review.

PMID:
22513936
[PubMed - indexed for MEDLINE]
13.

Suicidal behavior and depression in smoking cessation treatments.

Moore TJ, Furberg CD, Glenmullen J, Maltsberger JT, Singh S.

PLoS One. 2011;6(11):e27016. doi: 10.1371/journal.pone.0027016. Epub 2011 Nov 2.

PMID:
22073240
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.

Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J.

Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20.

PMID:
22818870
[PubMed - indexed for MEDLINE]
15.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD007253. doi: 10.1002/14651858.CD007253.pub3. Review.

PMID:
23450574
[PubMed - indexed for MEDLINE]
16.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
[PubMed - indexed for MEDLINE]
17.

An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.

Etter JF, Schneider NG.

Nicotine Tob Res. 2013 Jan;15(1):59-68. doi: 10.1093/ntr/nts084. Epub 2012 Apr 22.

PMID:
22529220
[PubMed - indexed for MEDLINE]
18.

Antidepressants for smoking cessation.

Hughes JR, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000031. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD000031.

PMID:
17253443
[PubMed - indexed for MEDLINE]
19.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
[PubMed - indexed for MEDLINE]
20.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk